Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell, Cutaneous × cemiplimab × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 20 Skin Neoplasms 7 Melanoma 7 Lung Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 4 Neoplasm Metastasis 4 Carcinoma, Squamous Cell 3 Carcinoma, Renal Cell 3 Breast Neoplasms 3 Adenocarcinoma 3 Urinary Bladder Neoplasms 2 Triple Negative Breast Neoplasms 2 Recurrence 2 Neoplasms 2 Mouth Neoplasms 2 Laryngeal Neoplasms 2 Glioblastoma 2 Colorectal Neoplasms 2 Carcinoma, Merkel Cell 2 Carcinoma, Large Cell 2 Carcinoma, Basal Cell 2 Carcinoma 2 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Solid Tumors 1 Solid Tumor 1 Sinonasal Squamous Cell Carcinoma 1 SMARCB1-Deficient Malignancies 1 Resectable Non-small Cell Lung Cancer 1 Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck 1

Interventions

Biopsy 4 fludarabine 3 Cyclophosphamide 3 romidepsin 2 pembrolizumab 2 mogamulizumab 2 Specimen Handling 2 tazemetostat 1 talimogene laherparepvec 1 ruxolitinib 1 hypericin 1 fludarabine phosphate 1 cc-486 1 belinostat 1 Valganciclovir 1 Urine Specimen Collection 1 Therapeutics 1 TNTCFP protein 1 Spinal Puncture 1 Polymerase Chain Reaction 1 Pharmacogenomic Variants 1 Nivolumab 1 Mycophenolic Acid 1 Mesna 1 Melphalan 1 Magnetic Resonance Spectroscopy 1 Magnetic Resonance Imaging 1 MEDI-570 1 Light 1 Lenalidomide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡